ezPvjlpTAvA https://histock.tw/talk/live.aspx?name=gtalk&id=1322 20250401 Queen怜

台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    67.5
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    208
  • 產業
    上櫃 生技醫療類股
  • 71人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-永豐金-員林 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw04/0104/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2055606570758085May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

永豐金-員林 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/28272.0000.0070.5025700.35%
2025/03/0300.000.165.4069.60-0.1483-0.02%
2025/02/21269.3500.0067.8025080.39%
2025/02/18262.5500.0062.6025020.40%
2025/02/170.163.5000.0062.200.15210.02%
2025/02/14161.6000.0063.0015430.18%
2025/02/13163.00761.2062.80-6574-1.04%
2025/02/12764.0000.0061.9075851.19%
2024/12/2600.00773.3066.60-7692-1.01%
2024/12/25771.6000.0074.0076831.02%
2024/12/1900.00263.4062.70-2695-0.29%
2024/12/11154.9000.0054.9016660.15%
2024/11/19167.1000.0067.4016670.15%
2024/10/241102.0000.00102.5016970.14%
2024/10/1600.000.2118.50117.00-0.2799-0.02%
2024/10/010.197.2000.0097.200.17870.01%
2024/09/300.1108.0000.00108.000.17770.01%
2024/09/270.1120.0000.00120.000.17960.01%
2024/09/261134.0000.00133.0017850.13%
2024/08/3000.000217.00216.0007920.00%
2024/08/290222.9000.00221.0007950.00%
2024/08/2100.000224.50225.0008020.00%
2024/08/200217.5000.00216.0008060.00%
2024/08/1300.001193.50189.00-1843-0.12%
2024/08/091185.0000.00203.5018240.12%
2024/07/2300.000160.00160.0006850.00%
2024/07/2200.000164.50164.0006670.00%
2024/07/190180.001.1182.31182.00-1.1650-0.16%
2024/07/180.1195.950192.14196.5006110.00%
2024/07/170184.2500.00191.0005890.01%
2024/07/161174.5000.00174.5015660.18%
2024/07/0800.000.2133.38138.50-0.2493-0.04%
2024/06/170.2108.0000.00108.000.23530.06%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音
 
 
513小時23